Title: INX-315, an oral, potent and selective CDK2 inhibitor in patients with CDK4/6 inhibitor resistant ER+/HER2- breast cancer or CCNE1 amplified solid tumors: phase 1 monotherapy dose escalation ...
Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from the sovleplenib ESLIM-01 Phase III trial, as well as several investigator-initiated studies of compounds ...
07, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc ... today announced acceptance of an abstract for presentation at the 5th annual HIV Research for Prevention Conference. The abstract summarizes research ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The Globe and Mail collects information about your online interactions with The Globe and Mail, the device you use to interact with us, the general location of your device (i.e. city/region ...
Metaphor: ReFantazio ponders these questions in both concrete and abstract ways through the lens ... It also feeds into that feeling of a globe-trotting adventure perpetuated by the main story ...
With its lightly decorated surfaces depicting abstract organic forms inspired by the natural world, Jessie Tait's Primavera dinner service for Midwinter, for example, evoked a new world miles away ...
today announced the presentation of new data in a Late-Breaking Abstract at the 2024 European Society of Gene and Cell Therapy (ESGCT) 31 st Annual Congress, held in Rome, Italy. The data highlight ...